GSK to pay Chimagen $300m upfront to develop autoimmune drug
GSK Plc., will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.
Drugs
Health
Medical
Drugs
Health
Pharma
Novartis to pay Monte Rosa $150m upfront for MGD drug candidates
Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise.
Drugs
Health
Medical
Molecular coating on X chromosomes may explain higher autoimmune susceptibility in women
Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases.
Drugs
Health
Pharma
Eli Lilly to acquire Dice Therapeutics by third quarter for $2.4 billion
HQ Team June 20, 2023: Eli Lilly and Company will acquire Dice Therapeutics for $2.4 billion to expand its immunology business, according to an.
Drugs
Medical
Pharma
Yemen, Lebanon allege India’s Celon Labs’ drug ‘substandard’
The WHO has issued a medical product alert on a contaminated cancer and autoimmune disease treatment drug made by Hyderabad, India-based Celon Laboratories,.